Russell Investments Group Ltd. boosted its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 23.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 169,344 shares of the company's stock after purchasing an additional 32,521 shares during the period. Russell Investments Group Ltd. owned approximately 0.08% of Docusign worth $13,910,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Hemington Wealth Management lifted its stake in Docusign by 318.1% during the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares during the last quarter. Golden State Wealth Management LLC lifted its position in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after acquiring an additional 322 shares in the last quarter. Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign in the 4th quarter valued at approximately $37,000. McIlrath & Eck LLC lifted its position in shares of Docusign by 476.0% in the 4th quarter. McIlrath & Eck LLC now owns 432 shares of the company's stock valued at $39,000 after acquiring an additional 357 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its position in shares of Docusign by 153.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock valued at $37,000 after acquiring an additional 274 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
DOCU has been the subject of several research analyst reports. UBS Group reduced their price target on shares of Docusign from $85.00 to $80.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. JPMorgan Chase & Co. reduced their price target on shares of Docusign from $81.00 to $77.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. JMP Securities restated a "market outperform" rating and issued a $124.00 price target on shares of Docusign in a research report on Tuesday, June 3rd. Bank of America reduced their price target on shares of Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Finally, Robert W. Baird reduced their price target on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Four investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. According to MarketBeat.com, Docusign currently has an average rating of "Hold" and an average target price of $89.77.
Get Our Latest Stock Analysis on DOCU
Docusign Stock Up 4.6%
Shares of DOCU traded up $3.2640 during mid-day trading on Friday, hitting $74.0040. 742,536 shares of the company's stock were exchanged, compared to its average volume of 2,571,685. The firm has a fifty day moving average of $75.45 and a two-hundred day moving average of $80.54. Docusign Inc. has a twelve month low of $54.31 and a twelve month high of $107.86. The stock has a market cap of $14.95 billion, a price-to-earnings ratio of 13.99, a P/E/G ratio of 26.53 and a beta of 1.01.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.81 by $0.09. The company had revenue of $763.65 million for the quarter, compared to analyst estimates of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. Docusign's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.82 EPS. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities analysts predict that Docusign Inc. will post 1.17 earnings per share for the current year.
Docusign announced that its Board of Directors has initiated a share repurchase program on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to buy up to 6.6% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's leadership believes its stock is undervalued.
Insider Activity
In other Docusign news, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, June 16th. The shares were sold at an average price of $74.37, for a total value of $39,713.58. Following the completion of the sale, the director directly owned 8,805 shares of the company's stock, valued at $654,827.85. This represents a 5.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the completion of the sale, the chief financial officer directly owned 110,723 shares of the company's stock, valued at approximately $8,282,080.40. This trade represents a 12.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 78,552 shares of company stock valued at $5,983,631 in the last quarter. 1.01% of the stock is currently owned by corporate insiders.
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.